Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA

Delayed Quote. Delayed  - 07/22 10:00:00 pm
11.21 USD   -1.58%
07/12 VANDA PHARMACEU : to Announce Second Quarter 2016 Financial Results ..
06/30 VANDA PHARMACEU : Why Investors Love These Biotech's Stocks? - Immun..
06/20 VANDA PHARMACEU : to Present at the JMP Securities Life Sciences Con..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
11.56(c) 11.06(c) 11.16(c) 11.39(c) 11.21(c) Last
413 989 419 872 748 899 446 106 411 346 Volume
+2.57% -4.33% +0.90% +2.06% -1.58% Change
More quotes
Financials ($)
Sales 2016 147 M
EBIT 2016 -36,1 M
Net income 2016 -30,2 M
Debt 2016 -
Yield 2016 -
Sales 2017 168 M
EBIT 2017 -4,41 M
Net income 2017 -5,04 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 3,29x
Capi. / Sales2017 2,88x
Capitalization 484 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its products portfolio includes HETLIOZ, Fanapt and Tradipitant, Trichostatin and AQW051.Vanda Pharmaceuticals was founded by... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
07/12 VANDA PHARMACEUTICALS : to Announce Second Quarter 2016 Financial Results on Jul..
06/30 VANDA PHARMACEUTICALS : to Present at the JMP Securities Life Sciences Conferenc..
06/30 VANDA PHARMACEUTICALS : Why Investors Love These Biotech's Stocks? - ImmunoGen, ..
06/24 VANDA PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-..
06/20 VANDA PHARMACEUTICALS : to Present at the JMP Securities Life Sciences Conferenc..
06/16 VANDA PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders..
06/15 VANDA PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (fo..
06/15 VANDA PHARMACEUTICALS : FDA Grants Fanapt® Three Years of Marketing Exclusivity ..
06/09 VANDA PHARMACEUTICALS : to Present at the Jefferies 2016 Healthcare Conference
06/03 VANDA PHARMACEUTICALS : to Present at the Jefferies 2016 Healthcare Conference
More news
Sector news : Bio Therapeutic Drugs
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12DJJuno to Resume Clinical Trial of Anticancer Treatment
07/09DJCorrections & Amplifications -- WSJ
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From -2-
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/15 Vanda nabs three-year market exclusivity for Fanapt for maintenance treatment..
05/27 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
05/26 FDA OKs expended use of Vanda's Fanapt for maintenance treatment of schizophr..
05/26 After Hours Gainers / Losers
05/23 Key FDA decisions coming this week
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends VANDA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 17,3 $
Spread / Average Target 54%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mihael Hristos Polymeropoulos President, Chief Executive Officer & Director
H. Thomas Watkins Chairman
James Patrick Kelly Chief Financial Officer, Treasurer & Senior VP
Paolo Baroldi Chief Medical Officer & Senior Vice President
Howard H. Pien Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VANDA PHARMACEUTICALS ..20.41%484
AMGEN, INC.2.06%124 454
GILEAD SCIENCES, INC.-14.47%115 269
CELGENE CORPORATION-10.22%83 285
REGENERON PHARMACEUTIC..-27.91%41 121
VERTEX PHARMACEUTICALS..-25.38%23 224
More Results